Industry Experts

Venita De Almeida has been deeply involved in the development of oncology therapeutics, including antibody-drug conjugates (ADCs), T-cell engagers (TCEs), antibodies, and fusion proteins. She has extensive experience spanning target validation, preclinical and translational research, and the advancement of multiple ADC and bispecific drug candidates through early- to mid-clinical development (Phase 1/2). Her expertise includes designing and executing research strategies that bridge discovery science and clinical development, including identifying and developing novel product concepts to address unmet needs in cancer therapy.